AF Global L38

SGD 0.109 +0.00% +0.00 Quote source time unavailable

Dividend history

Recorded rates may be provisional. Annual yields use today's price; they are not historical investment returns.

1 source record with missing or invalid ex-dates are omitted from dated history.

2026 year to date 10 records Yield at current price0.00% Annual dividend per shareSGD 0.00
Amount Ex Date Pay Date Particulars / source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
Offer
Details Original source
2024 2 records Yield at current price13.76% Annual dividend per shareSGD 0.015
Amount Ex Date Pay Date Particulars / source
SGD 0.035
Details Original source Reference: SG240807DECRXNJR
SGD 0.015
Details Original source Reference: SG240807DVCAHFC4
Annual totals, currencies and data coverage

Spot an error? Let us know.

Annual dividend per share is the calendar-year cash total, converted to the share-price currency using available exchange rates. Yield is that total divided by today's share price; it is not the historical investment return.

The current year is marked year to date. Its total includes ex-dates through today; future rows remain visible but are excluded. Amounts with missing data are unavailable, not zero.

Possible duplicate source records are shown together and can be expanded. Different confirmed references remain separate. Totals under review are withheld until the source identity is verified.

Free view: the latest five calendar years. Corporate-action dates are displayed as published; time-based summaries use SGT.

Earlier dividend history
32 earlier dividend records are hidden for non-members.

Background

LCD Global Investments Ltd (formerly known as L.C. Development Ltd) started out as a company specialising in traditional Chinese medicines in 1973 until September 1993 when it sold off the pharmaceutical component to concentrate on its property related business.
From there, the …

Full security profile